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THE UPTAKE OF 5-HYDROXYTRYPTAMINE, HISTAMINE, AND THEIR AMINO ACID
PRECURSORS BY NEOPLASTIC MAST CELLS* *
Neoplastic mast cells of the mouse not only synthesize histamine and
5-hydroxytryptamine (5-HT)"
' but can take up biogenic amines, 4 a
property also demonstrated by normal cells."'6 Previous experiments showed
that uptake of 5-HT and histamine,3 but not of the precursor amino acids,2
was inhibited by imipramine, and, moreover, that this drug was more
effective in inhibiting uptake of 5-HT than of histamine.' a-Methyldihy-
droxyphenylalanine inhibited uptake of 5-hydroxytryptophane (5-HTP)
but not of histidine2 or of either amine.3 It seemed appropriate to study the
effects of other subtances on the uptake of these amines and amino acids
in order to see how useful these cells may be for the study of transport.
At the same time, it was hoped to gain some insight to factors influencing
uptake. Similar studies on amines have been described recently by Day
and Stockbridge.'
METHODS
The P 815-X-I line of cells,' derived from the Dunn-Potter tumor, were grown in
the ascitic form in DBA/2 mice. Cells were removed by aspiration of the peritoneal
fluid and washed twice with a solution identical to that used to grow the cells in
culture' except that they lacked histidine. The cells were diluted with this medium
to give a suspension of 2 x 100 cells/ml; at higher concentrations the cells tended to
clump during the incubation. Four and .8 milliliters of the cell suspension were added
to test-tubes containing 0.1 ml. of a solution of isotopic material and 0.1 ml. of a
solution of the substance to be studied (or the same solvent without the substance).
The substances to be tested were dissolved in water whenever possible; some com-
pounds were insoluble in water, such as the steroids and bishydroxycoumarin, which
were dissolved in the minimum amount of ethanol and 0.1 N NaOH, respectively, and
then diluted with water. The source and labeling of radioactive 5-HT, histamine,
5-HTP, and histidine have been described.2'3 After incubation for two hours at 370 C.
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TABLE 1. PER CENT INHIBITION OF UPTAKE OF 5-HTP, HISTIDINE,
5-HT AND HISTAMINE
Sutbsta.nice or treatment Colc.
(mM.)
5-HTP Histidine 5-HT Histamine
Absence of both glucose
and air
Absence of glucose
2-Deoxyglucose
Phloridzin
Insulin
Malonate
Fluoride
Fluoride
Iodoacetate
Iodoacetate
Iodacetate
p-Chloromercuribenzoate
N-ethylmaleimide
Cystaniine
Formamidinie disulfide
Arsenite
Arsenite
2,4-Dinitrophenol
2,4-Dinitrophenol
Bishydroxycoumarin
Bradykinin
Hydrocortisone
Desoxycorticosterone
Testosterone
Progesterone
Estradiol
Diethylstilbestrol
Diethylstilbestrol
Ouabain
Ouabain
Bulbocapnine
Tyramine
Tyramine
Dopamine
Dopamine
Norepinephrine
Norepinephrine
Guanethidine
Bretylium
Bretylium
Morphine
Morphine
1.0
0.1
0.5 unit
10.0
1.0
0.1
1.0
0.1
0.01
0.1
10.0
4.0
4.0
1.0
0.1
1.0
0.1
0.1
0.002
0.03
0.03
0.03
0.03
0.03
0.03
0.003
1.0
0.1
0.03
0.07
0.007
0.07
0.007
0.07
0.007
0.1
1.0
0.1
1.0
0.1
89 91 88 90
42 46 27 23
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
17 13 11 15
0 0 0 0
90 95 94 91
65 72 66 70
9 9 11 8
95 90 91 92
100 100 96 98
100 100 100 100
84 89 81 83
98 96 72 74
36 42 21 26
44 47 50 48
18 16 14 17
34 37 44 39
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
64 53 59 62
0 0 0 0
21 20 69 53
0 0 32 12
0 0 29 12
0 0 47 82
0 0 0 36
0 0 27 50
0 0 0 0
0 0 0 43
0 ji 0 17
0 0 18 75
0 0 0 76
0 0 0 53
0 0 65 80
0 0 18 35
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TABLE 1. CONnNUED.
Substance or treatment Conc. 5-HTP Histidine 5-HT Histamine
(nAI.)
Mescaline 0.5 0 0 59 84
Mescaline 0.05 0 0 0 27
LSD-25 0.07 0 0 35 50
Phenylpyruvate 1.0 0 0 0 0
Phenyllactate 1.0 0 0 0 0
Phenylacetate 1.0 0 0 0 0
5-Fluorotryptophan 1.0 0 0 0 0
Uridine 10.0 0 0 45 39
Uridine 1.0 0 0 20 25
Cytidine 10.0 0 0 35 42
Cytidine 1.0 0 0 0 0
Benzyl-antiserotonin 0.03 0 0 82 85
Benzyl-antiserotonin 0.003 0 0 40 36
in air, the cells were collected by centrifugation and washed three times with ice-cold
0.9 per cent NaCl. The washed and packed cells were extracted once with 1.5 ml. of
1.0 N HCI. Early experiments showed that one or two additional extractions with
1.0 N HC1 removed only insignificant amounts of radioactive material; extraction
with 80 per cent acetone instead of HCI gave no higher yields of radioactivity, and
successive extraction with acetone and HC1, in either order, did not extract additional
amounts of radioactive material. Radioactivity was measured in a liquid scintillation
spectrometer. Uptake varied with each experiment but always exceeded 2,000 cpm.
In each instance the substance being studied was tested for its effect on the uptake of
all four labeled compounds at the same time. Each experiment was run at least twice
in triplicate; variation between experiments did not exceed eight per cent and
triplicates did not differ by more than five per cent.
RESULTS AND DISCUSSION
The results (Table 1) show that metabolic inhibitors depress uptake of
all four compounds, that some substances inhibit uptake of the amines
without influencing uptake of the amino acids, and that the uptake of
histamine and 5-HT can be selectively inhibited. It is risky to make in-
ferences about metabolic mechanisms from observations of the effects of
metabolic inhibitors, especially on a process in the whole cell where it is
possible that the inhibitors are reacting with cell components other than
those to which their effects are usually attributed. At most the effects of
the inhibitors may suggest tentative mechanisms. Uptake of both the amines
and the amino acids was practically abolished by withdrawing both oxygen
and glucose, but withdrawal of only glucose affected uptake of amino acids
more than of amines. This observation suggests that glucose metabolism
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is necessary for uptake of the amines and the amino acids, especially the
latter. Pfloridzin, insulin, and deoxyglucose were ineffective. Arsenite
similarly showed a greater effect on amino acid uptake, but the non-
specificity of this inhibitor precludes any inferences about the specific
enzymes being inhibited. Arsenite reacts with thiol groups, and in the con-
centrations used here can uncouple oxidative phosphorylation. The other
thiol-reacting substances-iodoacetate, p-chloromercuribenzoate, N-ethyl-
maleimide, cystamine, and formamidine disulfide-inhibited uptake of
amino acids and amines to an equal extent; similar results were obtained
with dinitrophenol and bishydroxycoumarin, both of which uncouple
oxidative-phosphorylation. Fluoride also inhibited uptake of all four com-
pounds. These results are in accord with the idea that energy is necessary
to support uptake of all four compounds and that thiol groups and the
magnesium ion function either directly in the uptake or in the enzymes
providing the energy for the uptake. Formation of ATP may be necessary
for uptake of both amino acids and amines, but the system utilizing the
ATP may not be the same: the sensitivity to ouabain of uptake of amines,
especially of 5-HT, did not obtain with the amino acids and may suggest
that the ATPase system8 functions in the uptake of the amines, especially
5-HT. Ouabain was the only steroid that showed activity in these experi-
ments, but, interestingly, diethylstilbesterol inhibited uptake of all four
compounds equally.
Many compounds inhibited uptake of amines without influencing uptake
of the amino acids. Like ouabain, bulbocapnine inhibited uptake of 5-HT
more than of histamine. Other compounds inhibited uptake of histamine
more than that of 5-HT: tyramine, dopamine, norepinephrine, guanethidine,
bretylium, morphine, mescaline, and LSD-25 (i.e., lysergic acid diethyl-
amide). Showing equal effects on uptake of histamine and 5-HT were
cytidine, uridine and benzyl-antiserotonin (i.e., 1-benzyl-2-methryl-3-(2-
aminoethyl)-5-methoxyndole, an antagonist of 5-HT).9 Day and Stock-
bridge7 obtained similar results with norepinephrine, guanethidine, and
LSD-25. The effect of LSD-25, an antogonist of 5-HT,' and the effect of
bulbocapnine, which inhibits histamine oxidation,'0 are in accord with the
observation of Day and Stockbridge' who noted that antihistamines were
more potent in inhibiting uptake of 5-HT than of histamine, and, con-
versely, that antagonists of 5-HT were more potent in inhibiting histamine
uptake. The ability to inhibit selectively the uptake of one amine implies
either different mechanisms of uptake for the two amines or that the
intracellular binding sites" for the amines can be selectively blocked and
are hence different.
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It is paradoxical that an active process for histamine uptake is sug-
gested by the effects of deprivation of oxygen and of glucose, by the effects
of metabolic inhibitors, and by early kinetic studies.8 However, more recent
kinetic studies7 suggest that histamine, unlike 5-HT, is taken up solely by
diffusion. These differences may rest either on temporal fluctuations in the
metabolic characteristics of the cells or on variants emerging from the
cell population. Temporal fluctuations have been shown in these cells,
grown in culture and in vivo, manifest in fluctuating concentrations of
5-HT and histamine.2 Other differences found in the metabolic character-
istics of these cells may more likely rest on genetic variants of the original
tumor. Attempts to demonstrate monoamine oxidase activity in these cells
with a variety of methods were unsuccessful,2'3 but this activity has recently
been described in a variant of this tumor.2 Hydroxylation of tryptophan
was clearly shown to be the rate-limiting step in the formation of 5-HT
from tryptophan: the activity of 5-HTP decarboxylase was so high that
5-HTP could only rarely be demonstrated in this laboratory by Schindler'
and Day and Green;2 yet in another laboratory,' decarboxylation of 5-HTP
was observed to be the rate-limiting reaction. Hydroxylation of phenyl-
alanine and tyrosine by these cells could not be demonstrated in this
laboratory,2 but has been shown recently in another laboratory.1' These
differences present problems, but nevertheless, the neoplastic mast cell,
capable of both taking up preformed amines and of synthesizing amines
from precursor amino acids, presents an uncommon tool for studying the
synthesis, uptake, and binding of amines.
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